Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 3, 2006, Pages 171-176

  Standley, Cynthia A ^a   Batia, Lyn ^a   Yueh, Gloria ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Hypertension; Magnesium; Nitric oxide; Pregnancy; Rats

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE; N(G) NITROARGININE METHYL ESTER;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART RATE; INTRAUTERINE GROWTH RETARDATION; MAGNESIUM BLOOD LEVEL; NONHUMAN; OSMOTIC MINIPUMP; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; FETAL GROWTH RETARDATION; FORELIMB; HEART RATE; MAGNESIUM SULFATE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 33646770274     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500448005     Document Type: Article

References (29)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research in Hypertension During Pregnancy. Hypertension 2003;41:437-445.
2. The Eclampsia Trial Collaborative Group. Which anti-convulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995;345:1455-1463.
3. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomized placebo-controlled trial. Lancet 2002;359:1877-1890.
4. Alexander BT, Bennett WA, Khalil RA, Granger JP. Preeclampsia: Linking placental ischemia with cardiovascular-renal dysfunction. News Physiol Sci 2001;16:282-286.
5. Khalil RA, Crews JK, Novak J, Kassab S, Granger JP. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 1998;31:1065-1069.
6. Buhimschi IA, Shi SQ, Saade GR, Garfield RE. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Am J Obstet Gynecol 2001;184:686-693.
7. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:1458-1466.
8. Zhang Y, Kaufman S. Effect of nitric oxide synthase inhibition on cardiovascular and hormonal regulation during pregnancy in the rat. Can J Physiol Pharmacol 2000;78:423-427.
9. Standley CA, Whitty JE, Mason BA, Cotton DB. Serum ionized magnesium levels in normal and preeclamptic gestation. Obstet Gynecol 1997;89:24-27.
10. Resnick LM. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 1992;93:11S-20S.
11. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260-1265.
12. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998;179:1359-1375.
13. Zuspan FP. Preeclampsia. In: Quilligan EJ, Zuspan FR, editors. Current therapy in obstetrics and gynecology. 5th ed. Philadelphia, USA: WB Saunders; 2000. pp 322-325.
14. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991;4:700-708.
15. Roggesnsack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999;33:83-89.
16. Paller MS. Hypertension in pregnancy. J Am Soc Nephrol 1998;9:314-321.
17. Scardo JA, Hogg BB, Newman RB. Favorable hemodynamic effects of magnesium sulfate in preeclampsia. Am J Obstet Gynecol 1995;173:1249-1253.
18. 4 is an effective antihypertensive agent in preeclampsia. Am J Obstet Gynecol 1999;180:S56.
19. Lu J, Pfister M, Ferrari P, Chen G, Sheiner L. Pharmacokinetic- pharmacodynamic modeling of magnesium plasma concentration and blood pressure in preeclamptic women. Clin Pharmacokinet 2002;41:1105-1113.
20. Kh R, Khullar M, Kashyap M, Pandhi P, Uppal R. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate-induced hypertension in rats. J Hypertens 2000; 18:919-926.
21. Touyz RM, Milne FJ. Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats. Am J Hypertens 1999; 12:757-765.
22. Wolf JP, Luthringer C, Berthelot A, Berthelay S. Blood pressure and plasma renin activity after magnesium supplementation in the spontaneously hypertensive rat: A study during development and established hypertension. Magnesium 1987;6:243-248.
23. Pandhi P, Saha L, Malhotra S. Effect of oral magnesium supplementation on experimental pre-eclampsia induced by prolonged blockade of nitric oxide synthesis in pregnant rats. Indian J Exp Biol 2002;40:349-351.
24. Senturk UK, Kaputlu I, Gunduz F, Kuru O, Gokalp O. Tissue and blood levels of zinc, copper, and magnesium in nitric oxide synthase blockade-induced hypertension. Biol Trace Elem Res 2000;77:97-106.
25. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension. Relationship to its actions on cardiac and vascular smooth muscle. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, diagnosis and management. 2nd ed. New York, NY: Raven Press; 1995. pp 1213-1242.
26. Barton JR, Sibai BM, Ahokas RA, Whybrew WD, Mercer BM. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am J Obstet Gynecol 1992;167:931-934.
27. G-nitro-L- arginine methyl ester): A new mechanistic model of vascular disruption. Teratol 1999;60:151-160.
28. Fantel AG, Nekahi N, Shepard TH, Cornel LM, Unis AS, Lemire RJ. The teratogenicity of N(omega)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, in rats. Reprod Toxicol 1997;11:709-717.
29. Walsh SW, Romney AD, Wang Y, Walsh MD. Magnesium sulfate attenuates peroxide-induced vasoconstriction in the human placenta. Am J Obstet Gynecol 1998;178:7-12.